cagrilintide and tirzepatide blend CAGRILINTIDE/SEMAGLUTIDE PEPTIDE (5MG/5MG) 10MG VIAL – UMBRELLA Labs What Is Cagrilintide Peptide Used

Acute soft tissue (strains, minor muscle) Typical early-change window Days to about 1 week What is happening Reduced discomfort and improved mobility as early repair activity ramps up Evidence base Preclinical + observation Gut-related support Typical early-change window Roughly 2 to 4 weeks What is happening Early research focus given BPC-157s origin in gastric juice Evidence base Preclinical-heavy Tendon / ligament Typical early-change window Roughly 4 to 8 weeks What is happening Slow-remodeling tissue with limited blood supply

Keep until the expiration date printed on the label

There is not enough evidence to say that semaglutide definitely causes blood clots, says Jodie Pepin, Pharm.D., clinical pharmacy program director at Harbor Health

Whatever it takes to lighten the stress in your life during recovery, now is the time to do it